Navigation Links
Ron Piervincenzi, Ph.D., Named Next CEO Of USP
Date:1/8/2014

ROCKVILLE, Md., Jan. 8, 2014 /PRNewswire-USNewswire/ -- The Board of Trustees of the United States Pharmacopeial Convention (USP) today announced that Ron Piervincenzi will become the Chief Executive Officer of USP and chair of USP's standards-setting body, the Council of Experts. Piervincenzi will assume these responsibilities February 1, 2014.

(Photo: http://photos.prnewswire.com/prnh/20140108/DC42659)

"I am excited and honored to lead USP's mission to improve global health," said Piervincenzi. "This is an outstanding organization doing life-changing work around the world, and I look forward to focusing the collective energy, expertise and knowledge of USP's global volunteers and staff on the challenges of the future."

"In Dr. Piervincenzi we have found an outstanding new leader for USP, which has seen unprecedented growth over the past several years," said USP Board of Trustees Chair, Thomas R. Temple, R.Ph., M.S. "I am excited about Dr. Piervincenzi's commitment to the next phase of USP's unique mission to develop and promote cutting edge global standards for pharmaceuticals, food and dietary supplements."

Dr. Piervincenzi was a Partner and leader in McKinsey & Company's Global Pharmaceutical and Medical Products Practice for 12 years where, among other responsibilities, he launched McKinsey's global drug safety, medical and regulatory service line.  Dr. Piervincenzi earned his M.S. and Ph.D. from Duke University in Biomedical Engineering with research focused on protein engineering.

Timothy R. Franson, B.S. Pharm., M.D., and President of the Convention added, "We have found an exceptional leader in Ron. His ability to motivate people, craft creative solutions to complex problems and the tremendous reputation and respect from his peers are the reasons why Ron was selected. We are delighted that he has accepted this challenge and are confident that USP is in great hands."

Outgoing CEO Roger L. Williams, M.D., oversaw an unprecedented period of growth for USP. During Dr. Williams' tenure USP transformed from being an important standard setting organization to a recognized leader in global health through the establishment of facilities in Africa, China, India, Brazil and Europe. USP embarked on an ambitious effort to create new modernized standards in USP's compendia and through these efforts improve access to good quality food and drugs.  USP is also a key partner with USAID, working to combat the harmful influx of substandard and counterfeit medicines in developing countries around the world and improve lives through enhanced pharmaceutical standards.

"Dr. Williams has had a remarkable tenure. He has transformed this organization in an indelible way and been a driving force in improving public standards and the organization is grateful for his lasting contributions," added Temple.

USP – Global Expertise, Trusted Standards, Improved Health
The U.S. Pharmacopeial Convention (USP) is a global health organization that improves lives through public standards and related programs that help ensure the quality, safety, and benefit of medicines and foods. USP's standards are used worldwide. For more information about USP visit http://www.usp.org.

CONTACT: Nils Hagen-Frederiksen
301-816-8268; nhf@usp.org


'/>"/>
SOURCE U.S. Pharmacopeial Convention
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Igenica Appoints Mary Haak-Frendscho, Ph.D., as Chief Executive Officer
2. Synteract Appoints Keith Kelson as Chief Financial Officer and Member of Executive Council and Philip Doren, Ph.D., as Vice President, Biometrics
3. Chimerix Appoints Michael D. Rogers, Ph.D., as Chief Development Officer
4. Igenica Appoints Thi-Sau Migone, Ph.D., as Chief Scientific Officer
5. Venaxis Appoints SomaLogic CMO and former Pfizer Executive Stephen A. Williams, M.D., Ph.D., to Board of Directors
6. Afraxis Appoints Carmine Stengone President and Chief Executive Officer, and Christopher Rex, Ph.D., Chief Scientific Officer
7. Epilepsy Foundation To Present Epilepsy Therapy Project Lifetime Accelerator Award To Henrik Klitgaard, Ph.D., Recognizing Contributions To New Therapies
8. Novira Therapeutics Expands Management Team with Appointment of Klaus Klumpp, Ph.D., the Former Global Head of Roches Virology Discovery Initiatives, as Vice President Discovery Research
9. Promentis Pharmaceuticals, Inc. Appoints Industry Veteran Chad Beyer, Ph.D., MBA, as President and CEO
10. Cardioxyl Pharmaceuticals Appoints Shi Yin Foo, M.D., Ph.D., As Chief Medical Officer
11. Actinium Pharmaceuticals Appoints Kaushik J. Dave, Ph.D., MBA As President, Chief Executive Officer And Director
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... CHEYENNE, Wyoming , Feb. 24, 2017  Xynomic ... company, today announced that it has acquired exclusive ... a potentially best-in-class innovative HDAC inhibitor targeting hematological ... total of 14 Phase 1 and 2 clinical ... Asia have already been completed, ...
(Date:2/23/2017)... LG Innotek hat heute die weltweit erste ... das 1,5-fache des 45-mW-Moduls der Konkurrenz. UV-C ... und 280 nm und eignet sich damit für Sterilisationsaufgaben. Es ... zerstört. Das Produkt von LG Innotek erzeugt UV-Strahlung im ... ...
(Date:2/23/2017)... Im Rahmen seiner Schlüsselwachstumsstrategie arbeitet die Guian ... Provinz Guizhou, 2017 mit dem Angebot von Anreize schaffenden Strategien ... einer eingebetteten Hightech-Schlüsselindustrie. Foto - http://mma.prnewswire.com/media/471342/First_CRH__CHina_Railway_High_Speed__Train_Enters_Guian.jpg ... ... ...
Breaking Medicine Technology:
(Date:2/24/2017)... ... February 24, 2017 , ... The International Association of Eating Disorders ... Beyond What You See” body image mannequin art competition. Selected from 15 submissions from ... the winner revealed at the 31st annual iaedp Symposium, March 22 – 26 in ...
(Date:2/24/2017)... ... February 24, 2017 , ... Castle Farms, the celebrated ... Giveaway, with the winning couple announced on Feb. 14, 2017, on Facebook. The ... local vendors: A Matter of Taste, Ryan Rousseau Enterprises, A Touch of Spring ...
(Date:2/23/2017)... ... February 23, 2017 , ... Rare Disease Report®, which is ... in Rare Disease Day events, hosted by the Rare Disease Legislative Advocates (RDLA) ... website, weekly e-newsletter and quarterly publication, will be conducting interviews with patients and ...
(Date:2/23/2017)... ... February 23, 2017 , ... EBSCO Information ... National Institute for Health and Care Excellence (NICE) framework. The agreement ... Health Service (NHS) to search, order and purchase medical and healthcare-related content through ...
(Date:2/23/2017)... ... 23, 2017 , ... Current Meditation , a new ... throughout the U.S. starting this spring. Current Meditation focuses on “meditation for the ... Current Meditation will be the first meditation concept in the U.S. offering franchising ...
Breaking Medicine News(10 mins):